Literature DB >> 2283891

Prognostic significance of general immune competence in acute leukemia.

B L Li1, J Hu, J Ye, X F Wang, Y G Shen, B B Li, Y C Chen, X S Lin, Y Q Chen.   

Abstract

The prognostic significance of lymphocyte transformation rate, E-RFC%, 29 degrees C E-RFC%, serum IgG, IgA, IgM and C3 levels were studied in 286 patients with acute leukemia. In acute lymphoblastic leukemia (ALL), the pretreatment immunological parameters were not related to whether the patients could achieve complete remission (CR), but the patients with E-RFC% greater than 30% before treatment or E-RFC% restored to normal after treatment had a significantly longer survival time. In acute nonlymphocytic leukemia (ANLL), pretreatment LTR and E-RFC% were significantly higher in patients who could achieve CR subsequently, the patients with higher pretreatment levels of LTR, E-RFC% or 29 degrees C E-RFC% survived significantly longer than patients with lower levels of these parameters, and the patients whose LTR could return to normal after treatment had a significantly higher CR rate and longer survival times. Except that the pretreatment IgM level was related to the survival of ANLL patients, serum levels of immunoglobulins and C3 had no prognostic value for both ALL and ANLL. In both ALL and ANLL, the immunological parameters changed significantly when relapse occurred.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2283891

Source DB:  PubMed          Journal:  Med Oncol Tumor Pharmacother        ISSN: 0736-0118


  7 in total

1.  [Concanavalin A-induced suppressor cell activity in patients with leukemia].

Authors:  J Hu; Y Su; X F Wang
Journal:  Zhonghua Nei Ke Za Zhi       Date:  1985-07

2.  Serial studies of immunocompetence of patients undergoing chemotherapy for acute leukemia.

Authors:  E M Hersh; J U Gutterman; G M Mavligit; K B McCredie; M A Burgess; A Matthews; E J Freireich
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

3.  Chemotherapy, immunocompetence, immunosuppression and prognosis in acute leukemia.

Authors:  E M Hersh; J P Whitecar; K B McCredie; G P Bodey; E J Freireich
Journal:  N Engl J Med       Date:  1971-11       Impact factor: 91.245

4.  Studies of T, B, and null lymphocytes during the course of acute lymphocytic leukemia.

Authors:  H W Hann; W T London; A E Evans
Journal:  Cancer       Date:  1977-04       Impact factor: 6.860

5.  Prognostic influence of pretreatment characteristics in adult acute lymphoblastic leukemia.

Authors:  J T Leimert; C P Burns; C G Wiltse; J O Armitage; W R Clarke
Journal:  Blood       Date:  1980-09       Impact factor: 22.113

6.  Prognostic value of cytologic parameters in acute myelogenous leukemia.

Authors:  R Zittoun; M Cadiou; C Bayle; S Suciu; G Solbu; M Hayat
Journal:  Cancer       Date:  1984-04-01       Impact factor: 6.860

7.  Adult acute lymphoblastic leukaemia: a study of prognostic features and response to treatment over a ten year period.

Authors:  R E Marcus; D Catovsky; S A Johnson; W M Gregory; J G Talavera; J M Goldman; D A Galton
Journal:  Br J Cancer       Date:  1986-02       Impact factor: 7.640

  7 in total
  1 in total

Review 1.  Current strategies for surgical management and adjuvant treatment of childhood papillary thyroid carcinoma.

Authors:  Geoffrey B Thompson; Ian D Hay
Journal:  World J Surg       Date:  2004-11-04       Impact factor: 3.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.